低分子量肝素与普通肝素治疗静脉血栓形成的相对疗效和安全性比较。 - Suppr | 超能文献

Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.

作者信息

Hirsh J

机构信息

Hamilton Civic Hospitals Research Centre, Henderson General Division, Ontario, Canada.

出版信息

Semin Thromb Hemost. 1996;22 Suppl 2:7-12; discussion 29-30.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis.低分子量肝素与普通肝素治疗静脉血栓形成的相对疗效和安全性比较。

Semin Thromb Hemost. 1996;22 Suppl 2:7-12; discussion 29-30.

2

Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.低分子量肝素与普通肝素治疗深静脉血栓形成的相对疗效和安全性比较。

Semin Hematol. 1997 Oct;34(4 Suppl 4):20-5.

3

Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?静脉血栓栓塞症的治疗：普通肝素还是低分子量肝素？

Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83.

4

Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.低分子量肝素用于静脉血栓形成的院外治疗：理论依据与临床结果

Thromb Haemost. 1997 Jul;78(1):689-92.

5

Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?

J Fam Pract. 1998 Sep;47(3):185-92.

6

Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.肝素和低分子量肝素治疗静脉血栓栓塞症。抗凝监测的黄昏。

Int Angiol. 1998 Dec;17(4):213-24.

7

[Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].

Bull Acad Natl Med. 1997 May;181(5):875-83; discussion 883-5.

8

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.低分子量肝素与普通肝素用于重大外科手术后血栓形成的预防：既往荟萃分析的更新

Br J Surg. 1997 Jun;84(6):750-9.

9

Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.低分子量肝素与普通肝素用于重大手术干预后血栓形成的预防：既往荟萃分析的更新

Br J Surg. 1998 Jun;85(6):872. doi: 10.1046/j.1365-2168.1998.00844.x.

10

Low-molecular-weight heparin for the treatment of deep vein thrombosis.低分子量肝素用于治疗深静脉血栓形成。

Pharmacotherapy. 1998 Jul-Aug;18(4):748-58.

引用本文的文献

1

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.肝素与癌症再探讨：涉及血小板、P选择素、癌黏蛋白和肿瘤转移的机制联系

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7. doi: 10.1073/pnas.061615598.

2

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.肝素和硫酸乙酰肝素糖胺聚糖与选择素的差异相互作用。关于使用普通肝素和低分子量肝素作为治疗药物的意义。

J Clin Invest. 1998 Feb 15;101(4):877-89. doi: 10.1172/JCI1509.